Reclaiming Your Time: How Sponsors Can Save Thousands Of Hours With Agentic AI

For nearly a decade, the clinical research industry has faced a stubborn reality: it still takes an average of eight months to move from site identification to study startup completion. Despite major technological advances, clinical trial timelines continue to lengthen, weighed down by operational bottlenecks and inefficiencies that occur between critical milestones. From regulatory reviews and site activation to patient enrollment and data reconciliation, each stage of the process introduces new sources of delay that collectively slow the path to innovation.

Now, a new class of technology is poised to shift that paradigm. By addressing the operational “white space” that has long plagued trial execution, this emerging approach offers a way to transform waiting time into working time — improving oversight, accelerating cycle times, and unlocking true end-to-end efficiency.

Discover how the next generation of clinical technology is redefining what’s possible in drug development.